At the Burke Neurological Institute (BNI), our researchers are diving deeper to discover new and innovative therapies and support for individuals living with Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth (CMT), Spinal Muscular Atrophy (SMA), and other related neuromuscular diseases.
Research scientists around the world are still carrying on with “The Mission” to conduct the science hope demands. This article by Dr. Cyril Eleftheriou, with contributions from Drs. Julia Kaiser, Paola Bianchimano and Carlo Corona of the Burke Neurological Institute outlines what scientists are focusing on in times of a PAUSE in experimentation.
